Back
Terns Pharmaceuticals 10K Form
Sell
44
TERN
Terns Pharmaceuticals
Last Price:
5.89
Seasonality Move:
55.51%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TERN News And Ratings
See the #1 stock for the next 7 days that we like better than TERN
TERN Financial Statistics
Sales & Book Value
| Annual Sales: | $1M |
|---|---|
| Cash Flow: | $-16.46M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.29 |
| Price / Book: | 1.35 |
Profitability
| EPS (TTM): | -1.18000 |
|---|---|
| Net Income (TTM): | $-88.07M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Terns Pharmaceuticals Earnings Forecast
Key Terns Pharmaceuticals Financial Ratios
- Per Share Earnings over the last 6 years have been positive in 3 years.
Terns Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | TERN |
| Website: | ternspharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TERN Technical Analysis vs Fundamental Analysis
Sell
44
Terns Pharmaceuticals (TERN)
is a Sell
Is Terns Pharmaceuticals a Buy or a Sell?
-
Terns Pharmaceuticals stock is rated a Sell
The current Terns Pharmaceuticals [TERN] share price is $5.79. The Score for TERN is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.